These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 7590122

  • 1. Effects of diltiazem and verapamil on ADP-induced rabbit platelet shape change and aggregation.
    Dehpour AR, Samadian T, Akhavan MM, Meysamee F, Delfan A.
    Gen Pharmacol; 1995 Oct; 26(6):1295-9. PubMed ID: 7590122
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.
    Kiyomoto A, Sasaki Y, Odawara A, Morita T.
    Circ Res; 1983 Feb; 52(2 Pt 2):I115-9. PubMed ID: 6831645
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers.
    Moore JB, Fuller BL, Falotico R, Tolman EL.
    Thromb Res; 1985 Nov 01; 40(3):401-11. PubMed ID: 2417362
    [Abstract] [Full Text] [Related]

  • 4. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
    Onoda JM, Sloane BF, Honn KV.
    Thromb Res; 1984 Jun 01; 34(5):367-78. PubMed ID: 6377570
    [Abstract] [Full Text] [Related]

  • 5. Influence of verapamil and diltiazem on aggregatory responses in cat and rabbit platelet rich plasma.
    Lippton HL, Horwitz PM, McNamara DB, Landry AZ, Kadowitz PJ.
    Prostaglandins Leukot Med; 1984 Oct 01; 16(1):121-30. PubMed ID: 6440150
    [Abstract] [Full Text] [Related]

  • 6. Antiaggregatory activity of N-methyl- and N-isobutyl-1,2-diphenyl ethanolamines in rat platelets.
    el Tahir KE, el-Naser MA, Ageel AM, el-Obeid HA, al-Rashood KA.
    Arch Int Pharmacodyn Ther; 1990 Oct 01; 307():162-71. PubMed ID: 2095711
    [Abstract] [Full Text] [Related]

  • 7. Effect of verapamil on platelet aggregation.
    Glusa E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Oct 01; 115(4):469-73. PubMed ID: 2465955
    [Abstract] [Full Text] [Related]

  • 8. Effects of verapamil and diltiazem on human platelet function.
    Addonizio VP, Fisher CA, Strauss JF, Wachtfogel YT, Colman RW, Josephson ME.
    Am J Physiol; 1986 Mar 01; 250(3 Pt 2):H366-71. PubMed ID: 3006516
    [Abstract] [Full Text] [Related]

  • 9. Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
    Glusa E, Bevan J, Heptinstall S.
    Thromb Res; 1989 Jul 15; 55(2):239-245. PubMed ID: 2528843
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of endothelial cells and calcium channel blockers on platelet aggregation.
    Yamada Y, Furui H, Furumichi T, Suzuki T, Yamauchi K, Yokota M, Hayashi H, Saito H.
    Jpn Heart J; 1990 Mar 15; 31(2):201-15. PubMed ID: 2113109
    [Abstract] [Full Text] [Related]

  • 11. The mode of rabbit platelet shape change and aggregation induced by theonezolide-A, a novel polyketide macrolide, isolated from the Okinawan marine sponge Theonella sp.
    Rho MC, Park YH, Sasaki S, Ishibashi M, Kondo K, Kobayashi J, Ohizumi Y.
    Can J Physiol Pharmacol; 1996 Feb 15; 74(2):193-9. PubMed ID: 8723032
    [Abstract] [Full Text] [Related]

  • 12. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet.
    Rybak ME, Renzulli LA.
    Thromb Haemost; 1992 Jan 23; 67(1):131-6. PubMed ID: 1319614
    [Abstract] [Full Text] [Related]

  • 13. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ, Leis LA, Francis GS.
    Circulation; 1986 Apr 23; 73(4):847-54. PubMed ID: 3004784
    [Abstract] [Full Text] [Related]

  • 14. Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.
    Ono H, Kimura M.
    Arzneimittelforschung; 1981 Apr 23; 31(7):1131-4. PubMed ID: 7196762
    [Abstract] [Full Text] [Related]

  • 15. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
    Timar J, Chopra H, Rong X, Hatfield JS, Fligiel SE, Onoda JM, Taylor JD, Honn KV.
    J Cancer Res Clin Oncol; 1992 Apr 23; 118(6):425-34. PubMed ID: 1377695
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of diltiazem and aspirin on platelet aggregation in cats.
    Behrend EN, Grauer GF, Greco DS, Rose BJ, Thrall MA.
    J Am Anim Hosp Assoc; 1996 Apr 23; 32(1):11-8. PubMed ID: 8963730
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers.
    Valone FH.
    Thromb Res; 1987 Mar 01; 45(5):427-35. PubMed ID: 3590086
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.
    Ware JA, Johnson PC, Smith M, Salzman EW.
    Circ Res; 1986 Jul 01; 59(1):39-42. PubMed ID: 3089642
    [Abstract] [Full Text] [Related]

  • 19. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F, Motamed M.
    Br J Pharmacol; 1976 Feb 01; 56(2):209-18. PubMed ID: 1252669
    [Abstract] [Full Text] [Related]

  • 20. [Experimental research on the action of isoptin and alkylenediamine derivatives on the aggregation capacity and the membrane-bound calcium level of thrombocytes].
    Mironiuk EP, Manevich EM, Piotrovskiĭ LB, Dumpis MA.
    Farmakol Toksikol; 1987 Feb 01; 50(2):42-6. PubMed ID: 3582633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.